- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/80 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 307/80
Total number of patents in this class: 347
10-year publication summary
|
22
|
18
|
22
|
18
|
19
|
19
|
17
|
22
|
12
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi | 4072 |
33 |
| Arthrosi Therapeutics, Inc. | 28 |
15 |
| Boehringer Ingelheim International GmbH | 4642 |
12 |
| BioCryst Pharmaceuticals, Inc. | 174 |
11 |
| Mcmaster University | 802 |
8 |
| Takeda Pharmaceutical Company Limited | 2708 |
7 |
| Allergan, Inc. | 2347 |
6 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 31 |
6 |
| Janssen Pharmaceutica N.V. | 3394 |
5 |
| China Pharmaceutical University | 301 |
5 |
| Yale University | 2394 |
5 |
| Biosplice Therapeutics, Inc. | 171 |
5 |
| LG Chem, Ltd. | 17635 |
4 |
| Merck Patent GmbH | 5815 |
4 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
4 |
| The Board of Trustees of the University of Illinois | 2702 |
4 |
| Bionomics Limited | 89 |
4 |
| Children's Hospital Medical Center | 712 |
4 |
| Les Laboratoires Servier | 537 |
4 |
| Promega Corporation | 574 |
4 |
| Other owners | 197 |